ImmuCell Corporation
ICCC$86M
Micro CapNASDAQIn Vitro & In Vivo Diagnostic Substances🇺🇸North AmericaPORTLAND
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 13, 2026
8dMarket Overview
Stock performance and key metrics
ICCC News
Catalyst Timeline
1 upcoming, 0 past
EarningsNext
ICCC Earnings Report
Aug 13, 2026Confirmed
FQ end 2026-06 | Call: 2026-08-14 15:00:00
How ICCC's past catalysts played out
Drug Pipeline
No drugs found in this phase.
📑
→Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
Catalyst Verdict
Full breakdown — the signals behind the verdict
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is ImmuCell Corporation's next FDA catalyst?→
ImmuCell Corporation's (ICCC) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ICCC biotech catalysts?→
Add ICCC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ImmuCell Corporation's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply